• Greenland Mines issued more than 12 million common shares to AnorTech, valued at approximately $3.5 million at closing.
• Anorthosite is a rock type abundant in Greenland and on the moon, and AnorTech is developing proprietary processes to extract high-value materials from it.
• The transaction moves Greenland closer to the midstream segment of the critical materials value chain.

Two companies with deep roots in Greenland’s mineral landscape have formalized a relationship that could reshape how each of them is valued. Greenland Mines (NASDAQ: GRML) has closed a strategic share exchange with AnorTech Inc. (TSX-V: ANOR; OTCQB: ANORF), a deal that gives Greenland Mines its first foothold in midstream critical materials processing while giving AnorTech access to a NASDAQ-listed partner with growing capital markets presence and a portfolio of world-class Greenland assets.

The transaction, announced June 16 and formally closed by the end of the month, is structured as a share exchange rather than a cash acquisition. Greenland Mines issued 12,400,000 of its common shares to AnorTech, valued at approximately $3.5 million at closing. In return, Greenland received 19,958,503 AnorTech shares, representing an initial 9.9% equity position. 

Greenland Mines also holds an option, exercisable within six months of closing, to acquire an additional 25,168,669 AnorTech shares, which would bring its total ownership to a maximum of 19.9%. Option shares would be priced at the greater of C$0.30 or the last closing price before exercise, with consideration paid through additional Greenland Mines shares based on a 10-day volume-weighted average price.

The lock-up terms reflect the long-term orientation of the deal. AnorTech shares issued to Greenland Mines carry a 60-month contractual lock-up. Greenland Mines shares issued to AnorTech are locked up in two equal tranches, half for 12 months and half for 24 months. Neither party is treating this as a short-term trade.

To understand why this matters for Greenland Mines, it helps to understand what AnorTech is building. AnorTech owns 100% of the Gronne Bjerg anorthosite project in Greenland, located approximately 80 kilometers northeast of Nuuk on open tidewater and adjacent to significant hydroelectric potential. Anorthosite is a rock type abundant in Greenland and on the moon, and AnorTech is developing proprietary processes to extract high-value materials from it. 

Its product pipeline includes zero-waste smelter-grade alumina, high purity alumina, next-generation alumina-based catalysts for CO2 capture, CO2-free refractory cement and advanced 3D-printable cement. The company filed a U.S. provisional patent in 2025 to protect its sustainable alumina process and has shipped 15 tonnes of Gronne Bjerg anorthosite to Ontario for pilot plant testing.

High-purity alumina in particular commands significant market interest. It is a critical input for synthetic sapphire used in LED lighting, semiconductor substrates and scratch-resistant glass for smartphones and watches, applications that spread across consumer electronics, automotive and advanced manufacturing. The global HPA market is projected to reach $12.21 billion by 2030, growing at a compound annual growth rate of 22.2%.

The connection to AnorTech also brings a history that is directly relevant to Greenland Mines. AnorTech owned and operated the Sarfartoq rare earths project in Greenland for many years before Greenland Mines signed a definitive agreement to acquire the project earlier this year. AnorTech’s 24 years of accumulated knowledge on that ground now becomes a direct resource for Greenland Mines rather than a competitor asset. 

For Greenland Mines, the deal does more than add an equity position. It moves the company closer to the midstream segment of the critical materials value chain. Greenland Mines president Bo Møller Stensgaard described it as a step that “expands Greenland Mines beyond upstream resource exposure” and “aligns directly with our vision of building a North Atlantic Critical Metals Corridor linking advantaged Greenland resource assets with industrial processing opportunities in allied jurisdictions such as Iceland or North America.”

That vision is taking concrete shape. Greenland Mines already holds the Skaergaard project, one of the largest palladium-gold deposits in the world, including a new drilling program targeting a doubling of the resource to approximately 50 million contained ounces of gold, palladium, and platinum. 

The Sarfartoq rare earths project adds an estimated 27 million kilograms of neodymium oxide and 8 million kilograms of praseodymium oxide, with neodymium and praseodymium representing 25% to 40% of total rare earth oxides, among the highest ratios reported globally for a carbonatite-hosted deposit. The AnorTech relationship now layers sustainable alumina and advanced materials optionality on top of that upstream base. 

For more information, visit www.GreenlandMines.com.

NOTE TO INVESTORS: The latest news and updates relating to GRML are available in the company’s newsroom at https://ibn.fm/GRML

• The company has appointed veteran medtech finance executive Sarah M. Romano as Chief Financial Officer, effective August 3, 2026.
• Romano brings more than two decades of experience in public-company finance, capital markets, and medical technology, having raised more than $100 million during her career.
• The appointment comes as SS Innovations continues pursuing U.S. FDA clearance for its SSi Mantra surgical robotic system while expanding internationally.
• The company recently graduated the inaugural class of its SS International Centre for Robotics Surgery (“SSICRS”) cardiac robotic surgery training program.
• SSICRS welcomed 33 healthcare professionals from seven countries, underscoring the company’s emphasis on surgeon education alongside technology deployment.

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has appointed veteran medical technology finance executive Sarah M. Romano as chief financial officer, adding public-company financial and capital markets experience as the surgical robotics developer continues its global expansion and advances regulatory initiatives. The appointment, effective August 3, comes at a time when SS Innovations is pursuing broader commercialization of its SSi Mantra robotic surgical platform while continuing preparations for U.S. Food and Drug Administration review (https://ibn.fm/91YyY).

Romano joins SS Innovations after serving as chief financial officer at Vicarious Surgical, another developer of robotic surgical technologies, where she oversaw financial and operational initiatives designed to reduce cash burn, strengthen the company’s balance sheet and support strategic growth objectives.

Earlier executive roles included chief financial officer positions at Entero Therapeutics and Kiora Pharmaceuticals, where she managed capital raises, SEC reporting, investor relations and strategic transactions.

According to the company, Romano has raised more than $100 million through public and private financings during her career and brings experience working with emerging public companies navigating periods of operational growth and capital formation.

The appointment reflects a common step among expanding medical technology companies seeking to strengthen financial leadership as commercialization efforts become increasingly complex. The company says Romano’s experience in public-company operations and capital markets will support its ongoing expansion as it works toward broader global adoption of the SSi Mantra surgical robotic system, a platform designed to provide robotic-assisted surgical capabilities across multiple specialties while emphasizing affordability and accessibility.

“We are thrilled to welcome Sarah as our Chief Financial Officer at this critical moment in our growth journey. As we continue our global expansion, including pursuing U.S. FDA approval of our advanced, cost-effective SSi Mantra surgical robotic system, Sarah brings strong financial leadership, keen strategic vision, and extensive capital markets experience,” said Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations. “She will play an integral role in scaling and enhancing our financial operations to accommodate our anticipated growth.”

The leadership addition follows another milestone announced earlier this month that highlights a different aspect of the company’s growth strategy. On July 7, SS Innovations announced that its subsidiary, the SS International Centre for Robotics Surgery (“SSICRS”), graduated the inaugural class of its Cardiac Robotic Surgery Training program (https://ibn.fm/7twsV).

The five-day program brought together 33 healthcare professionals from seven countries for classroom instruction, live surgical demonstrations and hands-on robotic training using the SSi Mantra system. Training focused on robotic-assisted cardiac procedures, including totally endoscopic coronary artery bypass surgery, mitral valve surgery, atrial septal defect repair and related cardiac interventions.

The curriculum combined lectures, laboratory sessions, virtual instruction, scientific discussions and live case observations to familiarize participants with robotic-assisted cardiac techniques. Faculty members included internationally recognized cardiac surgeons from leading institutions in the United States, Belgium and South Korea, reflecting the company’s effort to establish an international education platform alongside its commercial operations.

SSICRS plans to expand beyond cardiac surgery by offering condensed training programs covering additional specialties, including urology, gynecology, thoracic surgery, colorectal procedures, gastrointestinal surgery and general surgery. The training center also incorporates online educational modules that complement in-person instruction through recorded lectures, assessments and continuing educational support.

SS Innovations’ strategy combines technology development with physician training infrastructure intended to support long-term clinical utilization. The company’s broader business centers on its proprietary SSi Mantra robotic surgery platform and the complementary SSi Mudra surgical instruments.

The system supports a variety of minimally invasive surgical procedures, including cardiac surgery, and has increasingly attracted attention for its work in robotic telesurgery. As of June 2026, the company reported that more than 20 cardiac telesurgeries had been successfully performed using the SSi Mantra platform. While telesurgery remains an emerging field rather than the company’s primary commercial focus, the procedures demonstrate technical capabilities that may contribute to future development opportunities.

For more information, visit the company’s website at www.SSInnovations.com.

NOTE TO INVESTORS: The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII

• Forward Industries announced an expansion of its Solana treasury by over 500,000 Solana (SOL) during fiscal Q3 of 2026 at an average purchase price of around $79 per SOL.
• This brings Forward’s SOL treasury up to 7.55 million SOL as of June 30, 2026.
• During fiscal Q3, Forward sold 93,642 shares of common stock as part of its At The Market offering while delivering an annualized SOL-per-share growth of 36%.

Forward Industries (NASDAQ: FWDI), which continues to build and manage a large-scale Solana (SOL) treasury, announced that it acquired more than 500,000 SOL during fiscal Q3 of 2026, at an average purchase price of approximately $79 per SOL (https://ibn.fm/6wz2z).

This brings Forward’s SOL treasury up to 7.55 million SOL as of June 30, 2026, making it the largest SOL treasury company. Also during fiscal Q3 2026, as a part of its At The Market offering, Forward sold 93,642 shares of common stock while delivering an annualized SOL-per-share growth of 36%, which highlights Forward’s ability to raise capital from public markets in an accretive manner for shareholders.

Following its inclusion in both the Russell 2000 and Russell 3000 Indexes, Forward is positioned well to raise capital in public markets when its shares trade at a premium to net asset value (“NAV”).

This access to public capital is another tool for Forward to use alongside its industry-leading cost of capital, which it established using fwdSOL, the company’s proprietary liquid staking token, as collateral with institutional partners. This setup is beneficial as it lets Forward access liquidity, while also generating positive carry by borrowing against its SOL at a lower cost of capital than Forward’s staking yield of between 6.4% and 7.3%.

Speaking about Forward and how it performed this quarter, the Chief Investment Officer of Forward, Ryan Navi, said that “Our mandate is simple: maximize SOL per share and create long-term shareholder value. Our execution this quarter demonstrates our ability to employ multiple capital formation strategies to acquire additional SOL in a highly accretive manner.”

He also added that “By repurchasing shares when Forward trades at a discount to NAV and issuing equity when our shares trade at a premium, we dynamically allocate capital in a way that compounds SOL per share and enhances long-term intrinsic value. Our recent inclusion in the Russell 2000 and Russell 3000 further expands our access to institutional capital and broadens our investor base, creating another efficient avenue to fund SOL accumulation on terms that benefit our existing shareholders.”

About Forward Industries Inc. (NASDAQ: FWDI)

Forward Industries is building and managing one of the world’s largest Solana (SOL) treasuries, and is backed by many of the most influential investors in the digital space. Forward’s strategy is focused on creating long-term shareholder value by accumulating SOL and actively participating in the SOL ecosystem through various on-chain activities like staking, lending, and participating in decentralized finance (“DeFi”).

For more information, visit the Forward Industries website at www.ForwardIndustries.com.

NOTE TO INVESTORS: The latest news and updates relating to FWDI are available in the company’s newsroom at https://ibn.fm/FWDI

• The company has begun operations at its new North Texas engineering facility as it prepares to consolidate research, engineering and manufacturing activities.
• The relocation places the company closer to engineering talent, research institutions, aerospace companies and defense contractors in the Dallas-Fort Worth region.
• Expansion reflects American Fusion’s(TM) strategy of combining engineering development, intellectual property protection, and prototype testing as it advances toward commercialization.
• The company is advancing preparations for testing both its 500 kW and 5 MW Texatron(TM) Fusion Engine(TM) platforms.
• Negotiations continue with Texas Tech University regarding access to specialized testing infrastructure for the Texatron(TM) development program.
• American Fusion(TM) has filed 18 additional U.S. patent applications, expanding its intellectual property portfolio around fusion technologies.

American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy technologies, has entered the next phase of its development program by beginning operations at a new engineering facility in North Texas while continuing preparations for expanded testing of its proprietary Texatron(TM) Fusion Engine(TM) platform.

The company announced that engineering personnel have relocated into a temporary facility in the Dallas-Fort Worth metropolitan area as construction continues on its permanent headquarters, engineering shop and research laboratory (https://ibn.fm/CGUCP). The move marks the first stage of American Fusion’s(TM) transition from Midland, Texas, positioning the company closer to one of the country’s largest engineering and aerospace corridors. 

Management believes the new location offers improved access to experienced technical talent, major transportation infrastructure, research institutions, defense contractors and industrial partners that could support future technology development.

Once construction is completed over the coming weeks, the company expects to consolidate its engineering, laboratory, fabrication, assembly and administrative operations into a single integrated facility. “This integrated environment should streamline operations, improve collaboration, accelerate engineering development, and position American Fusion for the next stage of growth,” said Brent Nelson, Executive Chairman.

The relocation represents more than a change of address. Fusion development requires close coordination among physicists, engineers, fabrication specialists and testing personnel. Bringing those teams together in one location can help streamline prototype development, accelerate design revisions and improve communication as increasingly complex engineering systems move toward testing.

American Fusion(TM) says procurement of specialized laboratory systems, instrumentation, diagnostic equipment, fabrication materials and testing hardware is nearing completion as preparations continue for the next stage of its engineering program.

Those preparations are focused on the company’s Texatron(TM) Fusion Engine(TM) platform, which remains the centerpiece of its commercialization strategy. Management plans to conduct additional testing on both its existing 500-kilowatt Texatron(TM) Fusion Engine(TM) and a larger 5-megawatt pre-production model. The company expects the testing program to generate engineering data supporting continued technology development and independent evaluation of system performance.

American Fusion(TM) also continues negotiations regarding access to specialized testing infrastructure at Texas Tech University. While definitive agreements remain under discussion, management has previously indicated that access to university facilities could provide additional testing capabilities while the company’s own engineering infrastructure continues to expand. The company currently anticipates additional testing activities during July and August, subject to completion of facility preparations, equipment installation, applicable agreements and any required approvals.

Alongside its engineering expansion, American Fusion(TM) continues placing significant emphasis on intellectual property. The company announced that it has filed 18 additional U.S. patent applications since its previous patent update on July 1.

The applications cover multiple aspects of the Texatron(TM) Fusion Engine(TM) platform, including fusion confinement architectures, hollow toroidal chamber designs, plasma confinement concepts, reactor geometries, electromagnetic field generation, fuel injection systems and related engineering technologies. 

These filings add to what has become an expanding intellectual property strategy surrounding the company’s fusion platform. American Fusion(TM) says its patent strategy is intended to support long-term commercialization by protecting multiple aspects of the Texatron(TM) platform as engineering progresses.

The company is developing fusion technologies through its wholly owned subsidiary, Kepler Fusion Technologies, following the previously completed merger that led to its corporate rebranding as American Fusion(TM). Its strategy centers on developing modular, infrastructure-grade fusion energy systems that could eventually serve industrial, commercial, defense and grid-constrained applications.

Unlike conventional large-scale fusion projects, the company’s development efforts emphasize compact reactor architectures combined with scalable engineering and disciplined intellectual property development.

While commercial fusion energy remains an emerging industry requiring significant technical milestones before widespread deployment becomes feasible, investment across the sector has accelerated in recent years as both private companies and governments continue supporting research into alternative energy technologies. Across the industry, developers are pursuing a range of approaches to plasma confinement, fuel selection and reactor architecture in an effort to demonstrate systems capable of producing commercially useful energy while overcoming longstanding engineering challenges.

Management believes bringing scientists, engineers, fabrication personnel and administrative functions together within a single integrated engineering environment will improve collaboration while supporting future prototype evaluation.

As equipment installation continues and preparations for university-supported testing advance, the coming months are expected to center on generating additional engineering data from both the 500-kilowatt and 5-megawatt Texatron(TM) Fusion Engine(TM) platforms.

For more information, visit the company’s website at www.AmericanFusionEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to AMFN are available in the company’s newsroom at https://ibn.fm/AMFN

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

• SPARC AI has been registered as an authorized user under the AUKUS license-free environment, enabling streamlined technology transfers to approved U.S. and U.K. defense partners
• The company’s Overwatch platform delivers AI-powered GPS-denied geolocation and target acquisition capabilities for autonomous military systems
• The milestone reinforces SPARC AI’s strategy of accelerating defense technology commercialization through strategic partnerships and expanded access to allied defense markets

The nature of modern warfare is rapidly evolving. Recent conflicts have demonstrated that traditional GPS-based navigation can no longer be relied upon in contested environments, where electronic jamming and spoofing have become increasingly common. As militaries accelerate investments in autonomous drones, artificial intelligence, and next-generation battlefield technologies, solutions capable of operating without GPS are becoming strategic priorities. Against this backdrop, SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) has taken an important step toward expanding its presence in allied defense markets after being registered by the Australian Government as an authorized user under the AUKUS license-free environment, opening new opportunities across the United States and United Kingdom (ibn.fm/hIWYW).

The designation, established under Australia’s Defence Trade Controls Amendment Act 2024, removes permit requirements for most eligible controlled technologies transferred between authorized organizations in Australia, the United States, and the United Kingdom. For SPARC AI, the approval streamlines the process of supplying its proprietary defense technologies to approved partners, reducing regulatory barriers that have historically slowed international collaboration. CEO Anoosh Manzoori described the achievement as “a significant commercial and strategic milestone,” reflecting the company’s expanding role within one of the world’s most important allied defense partnerships.

The authorization is particularly significant for Overwatch, SPARC AI’s flagship AI-powered geolocation and target acquisition platform. Designed to operate in GPS-denied environments, Overwatch enables autonomous drones and other defense systems to navigate, identify, and track targets where conventional satellite navigation is unavailable or compromised. Rather than manufacturing drones itself, SPARC AI develops software that integrates into existing autonomous platforms, allowing defense manufacturers and systems integrators to enhance battlefield capabilities without redesigning hardware. As procurement increasingly favors software-defined technologies that can be deployed across multiple platforms, this approach positions the company to participate in a broad range of modernization programs.

The commercial implications extend beyond regulatory efficiency. By enabling permit-free transfers of eligible technologies to authorized partners, SPARC AI can engage more quickly with U.S. and U.K. defense contractors and drone manufacturers already deploying advanced autonomous systems. As Manzoori noted, “It lets us supply eligible controlled technology to authorized partners across the alliance without a standalone export permit, and it positions Overwatch inside the platforms our partners are already fielding.” Faster collaboration could help accelerate commercialization while significantly expanding the company’s addressable market across the AUKUS alliance.

The opportunity is supported by broader defense spending trends. Governments throughout NATO and AUKUS member nations continue increasing investments in autonomous systems, resilient navigation technologies, precision targeting, and AI-enabled battlefield intelligence as they adapt to increasingly contested operating environments. While defense remains the company’s primary commercial focus, SPARC AI’s GPS-denied geolocation technology also has potential applications in emergency response, border security, critical infrastructure monitoring, and industrial inspection, creating opportunities beyond traditional military procurement.

For SPARC AI, the AUKUS authorization represents more than a regulatory milestone. It validates the company’s strategic direction, strengthens its commercial positioning within three of the world’s largest defense markets, and reinforces its mission to deliver AI-powered geolocation technologies that enhance the effectiveness of autonomous operations. As demand for GPS-independent navigation and targeting capabilities continues to grow, the company appears well positioned to capitalize on one of the defense sector’s most important technology priorities.

For more information, visit the company’s website at https://sparcai.co.

NOTE TO INVESTORS: The latest news and updates relating to SPAIF are available in the company’s newsroom at https://ibn.fm/SPAIF

• MindWave’s platform targets the shift from passive reserve management toward programmable treasury assets, including Bitcoin, staking and validator strategies, and tokenized real-world assets.
• As corporations look beyond cash, bonds, and foreign exchange, MindWave is positioning at the infrastructure layer where the next generation of treasury is being built.
• Company leadership recently highlighted this vision during the “Inside the ICE House x Las Vegas” podcast, discussing the intersection of traditional finance, blockchain infrastructure and the future of corporate treasury management.

For decades, corporate treasury has revolved around a familiar toolkit. Cash protects liquidity, short-dated bonds preserve capital, foreign exchange manages currency exposure, and money-market instruments keep reserves productive without moving far out on the risk curve. That model is not disappearing, but a second financial infrastructure is forming beside it. Bitcoin has entered corporate balance sheets, tokenized real-world assets have moved tens of billions of dollars onto blockchains, and institutions are testing settlement and reporting on digital rails. Treasury is beginning to shift from holding assets toward managing programmable ones. MindWave Innovations (NYSE American: APUS) is building infrastructure around that transition.

From Accumulation to Discipline

The first phase of the corporate Bitcoin movement was about accumulation. Nearly 200 public companies now hold roughly 1.28 million bitcoin between them. But the model is being stress-tested. Bitcoin’s prolonged downturn has pressured treasury-company valuations, leaving several of them trading at or below the value of the coins they hold. The clearest signal came in early July 2026, when Strategy, the largest corporate holder, sold 3,588 bitcoin for about $216 million to fund preferred dividends and rebuild cash, its largest sale since it began buying in 2020 and a reversal of years of never-sell messaging. The question is moving from how much Bitcoin a company can acquire to how well those reserves are regulated. That is where MindWave positions its treasury framework.

Once digital assets reach a public-company balance sheet, custody stops being a crypto question and becomes a boardroom one. Who controls the assets, what approvals regulate their movement, how are they segregated, and what protects against key loss or technical failure? MindWave’s framework is designed around segregated, board-controlled custody with policy-based controls and insured custody structures, intended to align digital-asset holdings with the authority and oversight a board already expects. The aim is not to make a corporate treasury behave like a crypto fund. It is to bring digital assets inside the same discipline a company applies to cash and securities.

Yield Changes the Risk Equation

Traditional treasury assets earn income through interest and other established mechanisms. Bitcoin does not generate yield on its own. Producing a return from digital assets requires active strategies, and those strategies carry risks that have to be identified and constrained. MindWave is developing an AI-enabled yield engine intended to ingest market data, generate signals, and allocate across several approaches, including staking rewards on Proof-of-Stake networks, validator-node infrastructure, derivatives-based income, and liquidity provisioning. The thesis is not that digital-asset yield is passive or safe. It is that institutional adoption needs a technology layer that can evaluate opportunities, execute, and measure performance within defined risk limits. That is what separates active reserve management from simple accumulation.

The Asset Base Keeps Expanding

Bitcoin is only one part of the shift. Tokenized real-world assets, on-chain versions of Treasuries, private credit, and commodities, have grown into a market estimated above $30 billion by some trackers, though the figure varies widely by methodology. It remains small against traditional finance, but the direction is clear: instruments that once lived only in custodial accounts and legacy databases are moving onto blockchain rails. MindWave’s roadmap extends into real-world-asset tokenization, pointing toward a treasury that no longer faces a binary choice between cash and cryptocurrency. A finance team could eventually manage Bitcoin, tokenized Treasury exposure, and staking positions through a connected infrastructure, where interoperability itself becomes a treasury function.

Reporting and Settlement Move On-Chain

Traditional treasury reporting reconciles records after the fact across banks, custodians, and internal systems. Blockchain rails change that architecture, creating verifiable transaction histories and enabling settlement on shared networks, with tokenized assets offering near-continuous access and faster settlement. Legal, custody, and liquidity structures still determine what institutions can actually use. MindWave positions transparent reporting and blockchain-based infrastructure as part of its treasury model, with the goal of giving corporations clearer visibility into digital-asset activity alongside the controls that govern how it is held and deployed.

Treasury Is Becoming Software

Cash, bonds, and foreign exchange are not being erased. The toolkit is expanding, and the systems required to govern it are growing more complex. Traditional treasury managed money through banks and custodians. The next generation may manage digital assets, tokenized securities, and on-chain strategies through software, holding them, deploying them, and reporting on them inside one framework. MindWave Innovations is building for that version of treasury. That vision was recently highlighted on the “Inside the ICE House x Las Vegas” podcast, where MindWave leadership discussed the convergence of traditional finance and digital-asset infrastructure, underscoring the growing institutional focus on blockchain-based treasury management and financial innovation.

For more information, visit the company’s website at www.MindWaveDAO.com

NOTE TO INVESTORS: The latest news and updates relating to APUS are available in the company’s newsroom at https://ibn.fm/APUS

• Earth Science Tech has positioned itself within the rapidly evolving telehealth industry, through its investments into subsidiaries such as DOConsultations LLC and Las Villas Health Care Inc.
• The company is capitalizing on the surging demand and clinical effectiveness of peptide therapies, an industry expected to hit $249 billion by 2033.
• ETST’s success has been built on its proprietary tech and IT infrastructure, a significant competitive edge, and continues to push innovative tech development and expand vertical integration.

Earth Science Tech (OTC: ETST), a strategic holding company building value by acquiring and actively managing operating businesses in pharmaceuticals, telemedicine, healthcare services, real estate, and select consumer markets, continues to redefine its vertically integrated market position while advancing technical innovation. Through its proprietary tech, along with its understanding of the market, where it is able to identify unique opportunities, the company is steadily growing its market share, tapping into markets that are projected to grow tremendously over the coming years.

ETST has positioned itself within the rapidly evolving telehealth industry, a market that is projected to be valued at $251.5 billion by 2030, reflecting a CAGR of 11.3% between 2025 and 2030 (https://ibn.fm/EiRW6). Through its investments into subsidiaries including DOConsultations LLC and Las Villas Health Care Inc., the company now offers both online and brick-and-mortar telehealth healthcare services, specializing in wellness health and services, as well as direct-to-patient delivery through partner pharmacies.

ETST is also capitalizing on the surging demand of peptide therapies, an industry that is currently estimated at $164 billion, projected to hit $249.6 billion by 2033, representing a CAGR of 8.7%. North America alone commands 61.9% of the global revenue share, and is a market ETST is tapping into with its telehealth services (https://ibn.fm/Jq8Z8).

The success of these services will be built on the company’s proprietary tech and IT infrastructure. ETST’s in-house IT team is known for building custom tech stacks from scratch, a strength that has made the company known for its tailored solutions that optimize operational efficiency and improve profit margins across all of its divisions. This represents a significant competitive edge for the company, and one that allows it to deliver value to its customers, while stamping its position as a leader in the market.

ETST has an unmatched fully integrated doctor network, dubbed MyOnlineConsultation.com, delivering both technology and clinical staffing solutions to digital health companies (https://ibn.fm/bU8E6). Parties interested in the service gain access to turnkey technology, a scalable platform handling live video and consultations, engineered to sync data seamlessly between providers and pharmacies. They also gain access to a credentialed network of licensed prescribers, coupled with direct routing to the pharmacy of their choice.

For more information, visit the company’s website at www.EarthScienceTech.com.

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising.

• The commercial space industry is entering a new phase of growth, driven by expanding launch capabilities, reusable platforms, commercial space stations, robotics, orbital power systems and other foundational infrastructure.
• As more infrastructure is built, costs decline, enabling new technologies, services and business models that further accelerate industry expansion.
• Planet Ventures’ portfolio is positioned to benefit from this cycle through investments in companies developing technologies that support the next generation of the commercial space economy.

The commercial space industry is experiencing rapid expansion as critical infrastructure continues to evolve. Advances in reusable launch systems, commercial space stations, satellite constellations, orbital power networks and robotics are laying the foundation for a more accessible and scalable space economy.

As this infrastructure matures, the cost of operating in space continues to decline. Improvements in manufacturing, economies of scale, launch efficiency and resource utilization are making it more affordable for companies to develop new products and services. Lower barriers to entry encourage further innovation, creating a self-reinforcing cycle in which new infrastructure enables new businesses, which in turn drives demand for even more infrastructure.

This “snowball effect” is helping transform the commercial space industry from a collection of isolated technologies into an interconnected ecosystem capable of supporting long-term growth across multiple markets.

Planet Ventures (CSE: PXI) (OTC: PNXPF) is positioning itself to capitalize on this evolution through a portfolio of investments in innovative space and aerospace companies developing technologies that support the industry’s expanding infrastructure.

The portfolio is full of cutting-edge space solutions that aim to push the industry forward and support the growth of space infrastructure in general.

This includes:

• Mantis Space – Developing what it describes as the world’s first orbital power grid to transform how satellites generate and distribute energy.
• Antaris Inc. – Creator of an AI-powered operating system designed to simplify satellite constellation design, simulation and operations.
• Galactic Resource Utilization Space Inc. – Working to develop the world’s first lunar hotel, with a targeted opening in 2032.
• General Astronautics – Building autonomous robotic systems designed for microgravity research and development.
• Lux Aeterna – Developing what it aims to be the world’s first fully reusable satellite platform.

Through these investments, Planet Ventures provides shareholders with exposure to emerging opportunities across the rapidly expanding space economy, including innovative private companies that are typically accessible only to venture capital and institutional investors.

The company’s strategy centers on identifying businesses developing technologies that can help shape the future of commercial space while creating long-term value for shareholders as the industry’s infrastructure continues to expand.

Planet Ventures is led by CEO Etienne Moshevich alongside Bora Uygen, Head of Space Investments. Uygen brings extensive experience investing in early-stage technology companies, with a particular focus on the space sector, where he has helped identify and support innovative startups developing next-generation technologies. Complimenting Moshevich’s deep background in capital markets, private investing, and the evaluation and financing of growth companies across multiple sectors, provides Planet Ventures with a leadership team well positioned to identify and capitalize on emerging opportunities.

For more information, visit www.PlanetVenturesInc.com.

NOTE TO INVESTORS: The latest news and updates relating to PNXPF are available in the company’s newsroom at https://ibn.fm/PNXPF

Disclaimer

Investor Brand Network (“We” or “Us”) are not securities dealers or brokers, investment advisers or financial advisers, and you should not rely on the information herein as investment advice. Planet Ventures Inc. will make aggregate payments of $100,000 to us to provide marketing services for a term of 1 year. This article is informational only and is solely for use by prospective investors in determining whether to seek additional information. This does not constitute an offer to sell or a solicitation of an offer to buy any securities. Our stock profiles are intended to highlight certain companies for your further investigation; they are not stock recommendations or constitute an offer or sale of the referenced securities. The securities issued by the companies we profile should be considered high risk; if you do invest despite these warnings, you may lose your entire investment. Please do your own research before investing, including reading the companies’ SEDAR+ and SEC filings, press releases, and risk disclosures. 

Forward-Looking Statements

This document contains forward-looking statements within the meaning of applicable securities legislation. Such statements include, without limitation, statements regarding: Planet Ventures’ investment strategy and objectives; anticipated developments in the commercial space industry, including the growth of orbital energy and space robotics markets; the projected growth of the global space economy; Planet Ventures’ expectations regarding the strategic importance of its investments in Mantis Space and General Astronautics; the anticipated role of orbital energy technologies and robotic servicing systems in future in-orbit operations; and the potential for these technologies to become foundational to the next generation of commercial space activity.

Forward-looking statements are not guarantees of future performance. Readers are cautioned not to place undue reliance on forward-looking statements. The forward-looking statements contained in this document are made as of the date hereof and Planet Ventures undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws.

Risk Factors

Investing in Planet Ventures and its portfolio companies involves a high degree of risk. The following is a summary of key risk factors. This is not an exhaustive list, and additional risks may exist that are not currently known:

• Early-Stage Investment Risk. Portfolio companies have limited operating histories and are pre-revenue. Investments are speculative and may result in a total loss of capital.
• Technology Risk. The orbital energy and lunar habitation technologies underlying the Company’s investments are unproven at commercial scale and may not be successfully developed or deployed.
• Regulatory Risk. Space sector operations require licenses and approvals from domestic and international regulatory bodies. Failure to obtain or maintain these could materially delay or prevent operations.
• Market Risk. Commercial demand for in-space power systems and lunar services has not been established at scale. Projected market growth may not be realized within anticipated timeframes.
• Liquidity Risk. Investments in private, early-stage companies are illiquid. There is no guarantee of a market for these securities or the ability to exit on favorable terms.
• Capital Risk. Portfolio companies may require additional funding that may not be available, or may be available only on dilutive or restrictive terms.
• Macroeconomic and Geopolitical Risk. Adverse macroeconomic conditions or geopolitical developments could disrupt the Company’s investment strategy or the operations of portfolio companies.
• Key Personnel Risk. The Company’s performance depends in part on retaining key personnel and advisors. Loss of key individuals could adversely affect the Company’s operations and investment activities.

• SDR Drone’s common technology architecture supports 13 production platforms across eight application domains, from tactical operations and wildfire surveillance to agriculture and heavy-lift logistics
• The SDR-ONE integrated motherboard combines flight control, controllers, and communications on a single circuit board, reducing component count by 40% and production cost by roughly 30% against discrete-board designs
• Developed over three decades by South Korea-based Sundori Drone, the technology serves programs across the Korean Army, Navy, Air Force, Police, and Fire Department and has trained more than 10,000 pilots

The commercial and defense drone market is expanding quickly. South Korea alone has redirected roughly KRW 3.3 trillion (about $2.14 billion) once earmarked for attack-helicopter programs toward drone procurement and authorized an additional $2.4 billion for drone-related spending. Yet much of the industry still treats unmanned aircraft as single-purpose machines. One platform is built for surveillance, another for mapping, a third for cargo, and each new mission can demand a different airframe, communications package, and control system. The result is fragmented fleets that grow harder and costlier to operate at scale. SDR Drone, Inc. (f.k.a. Hallmark Venture Group Inc. (OTC: HLLK), approaches the problem from the opposite direction, advancing a common technology architecture that moves across missions by changing payload and software rather than rebuilding the aircraft. Developed over more than three decades by South Korea-based Sundori Drone, the platform spans 13 production models across eight application domains.

One Architecture Behind Every Aircraft

At the center of the platform is the SDR Multi Flight Control System, an AI-enabled architecture that supports autonomous operation, formation flight, collision avoidance, and coordinated fleets. Leader-follower tracking and one-touch controls put multiple aircraft into W, V, I, and custom patterns while real-time path planning reroutes around obstacles. The SDR-ONE motherboard applies the same logic to hardware, combining flight control, controllers, and communications on a single circuit board instead of spreading them across discrete parts. That consolidation removes roughly 40% of the components a conventional design requires and cuts production cost by about 30%. Communications run over a Flying Ad-hoc Network in which each drone relays communications for the others, extending operations beyond conventional ground-link limitations, with KCMVP-certified encryption and frequency-hopping countermeasures for contested airspace and fully domestic component sourcing for supply-chain security. Together these systems form the common layer that lets one platform shift between missions.

From Refinery Perimeters to Wildfire Lines

For critical-infrastructure operators, tethered platforms hold stations roughly 100 meters above refineries, substations, pipelines, and port perimeters, streaming continuous high-resolution and thermal imagery while drawing power through the tether, and a full site fleet runs from one ground-control station. Change the mission package and the same architecture becomes wildfire surveillance. Long-endurance aircraft fly pre-programmed routes, electro-optical and infrared sensors pick up heat signatures and smoke while a fire is still small, and detections downlink to fire authorities with live coordinates, with VTOL endurance reaching ten hours. Search and rescue apply it differently, using thermal sensors to find body heat through darkness and undergrowth and searchlight payloads for night operations. In disaster response, crews stream live imagery to incident command, map damage through photogrammetry, and hold 24-hour tethered overwatch above zones cut off from the ground.

The Same Airframe Goes to Work

The commercial side runs on the same stack. Smart-farm operations coordinate spraying, multispectral crop sensing, and yield mapping across multiple aircraft flown by a single operator, scaling from one parcel to a regional cooperative, an approach already demonstrated in multi-drone formation farming in South Korea. In logistics, heavy-lift platforms carry payloads up to 40 kilograms to remote, island, and mountain sites that trucks and helicopters reach only at high cost, and the same airframes swap in LiDAR and photogrammetry sensors to inspect pipelines, transmission lines, and large survey areas. The point is not that SDR sells several drones. It is that one flight-control, avionics, and communications layer underlies all of them, so an improvement to the SDR-ONE board, the control software, or the mesh network propagates across the entire portfolio rather than staying trapped in a single product.

Defense Pedigree, Not a Blank Sheet

The same architecture carries tactical ISR, loitering strike, resupply, and swarm-coordinated operations, and it arrives with an operating history most early-stage competitors cannot match. Built through more than three decades of engineering at Sundori Drone, the technology supports government-approved training programs serving the Korean Army, Navy, and Air Force, as well as Police and Fire Department operators. Those training platforms hold roughly 70% of the Korean Army training-drone market, more than 10,000 pilots have qualified through the training ecosystem, and the fleet has flown over 500 field missions. Hallmark is a newly formed commercialization vehicle, but the engineering underneath it does not start from a blank sheet.

A Different Way to Scale a Drone Company

The former company, Hallmark Venture Group, acquired worldwide rights to the Sundori technology portfolio in June 2026, including trade secrets, manufacturing know-how, software, AI models, and the innovations behind twelve Korean patents. Now renamed SDR Drone Inc., the company is targeting defense, public-safety, and industrial markets across the United States and allied jurisdictions through licensing, partnerships, and technology-transfer programs. The premise is a single engineering decision: integrate the core architecture once, then adapt the mission through payload and software. In a market increasingly shaped by swarm operations, secure communications, sovereign supply chains, and demand well beyond defense, that model gives SDR exposure across sectors without treating every application as a new aircraft program. From a refinery perimeter to a wildfire line to contested airspace, the mission changes. The architecture underneath does not.

For more information, visit www.SDRDrone.com. 

NOTE TO INVESTORS: The latest news and updates relating to HLLK are available in the company’s newsroom at https://ibn.fm/HLLK

• Artificial intelligence is becoming an increasingly important tool for drug discovery, with major pharmaceutical companies expanding AI collaborations across oncology and immunology. 
• VERAXA Biotech has partnered with AI-focused contract research organization Ardigen to strengthen discovery efforts for its BiTAC(R) cancer therapy platform.
• The collaboration aims to identify optimal dual-target combinations for T-cell engagers and antibody-drug conjugates while reducing development risks.
• VERAXA’s Boolean “AND-gated” BiTAC(R) technology presents a use case that may be particularly well suited for AI-assisted target selection and therapeutic design.
• AI analysis of historical clinical and preclinical datasets could help identify promising targets that were previously abandoned because of safety concerns.
• The partnership reflects a broader trend toward combining computational biology with next-generation antibody therapeutics to improve research productivity.

Artificial intelligence is becoming an increasingly important component of pharmaceutical research, with companies using machine learning to analyze complex biological data, identify drug targets and improve clinical development decisions. Against that backdrop, VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, announced a collaboration with AI-focused research partner Ardigen that is intended to strengthen development of the company’s BiTAC(R) oncology platform through AI-enabled target discovery and validation (https://ibn.fm/yoDH5). 

The agreement brings together VERAXA’s antibody engineering capabilities with Ardigen’s expertise in artificial intelligence, computational biology and bioinformatics. Ardigen, headquartered in Kraków, Poland, with U.S. operations in San Francisco, has supported more than 700 discovery projects for biotechnology and pharmaceutical organizations using AI-driven analytical platforms.

The collaboration illustrates how AI is moving beyond administrative applications into one of the most technically demanding areas of biotechnology: discovering and optimizing new medicines. That trend has accelerated across the pharmaceutical industry during the past two years.

Technology companies are investing heavily in scientific AI models specifically designed for research. Anthropic recently introduced Claude for Science, an initiative focused on computational biology, life sciences, and drug discovery applications, reflecting growing interest in applying large language models and advanced AI systems to scientific research. 

Large pharmaceutical companies are also expanding collaborations with specialized AI developers. Earlier this year, Takeda Pharmaceutical, Japan’s leading drug producer, entered a multi-target agreement with AI biotech company Insilico Medicine that could reach up to approximately $1.2 billion in milestone payments and commercial value, combining Takeda’s drug development expertise with Insilico’s generative AI platform for discovering new therapeutics. 

Similarly, Boehringer Ingelheim expanded its collaboration with ImmunAI to apply AI-based immune system mapping to immunology research and T-cell biology, another area closely related to modern antibody therapeutics.

These agreements illustrate a broader shift within drug development. Rather than relying solely on traditional laboratory screening, biotechnology companies are increasingly using AI to prioritize targets, analyze multimodal datasets, identify biomarkers, and improve candidate selection before therapies enter expensive clinical development.

For VERAXA in particular, the potential advantages extend beyond simply accelerating discovery. The company’s development strategy centers on its proprietary BiTAC(R)platform, which is designed to create conditionally active antibody therapeutics, including bispecific T-cell engagers (“TCEs”) and antibody-drug conjugates (“ADCs”).

Unlike conventional antibody therapies that recognize a single target, BiTAC(R) molecules employ Boolean “AND-gate” logic. That means activation occurs only when two separate cancer-associated targets are simultaneously expressed on the same cell. The objective is to reduce one of oncology’s persistent challenges: on-target, off-tumor toxicity. Many highly potent cancer therapies have demonstrated encouraging anti-tumor activity but produced unacceptable side effects because healthy tissue also expressed the intended target.

VERAXA believes requiring two targets for activation could widen the therapeutic window by improving tumor selectivity while limiting damage to normal tissue. Selecting the right target combinations, however, presents a significant scientific challenge. Researchers must evaluate enormous amounts of genomic, proteomic and clinical information to identify combinations that maximize efficacy while minimizing toxicity. This is where AI may provide particular value.

According to VERAXA, its collaboration with Ardigen will initially focus on developing AI-enabled computational models capable of identifying synergistic cancer target pairs for future BiTAC(R) therapeutics. Because BiTAC(R) molecules depend on dual-target biology, machine learning can potentially analyze datasets that would be difficult to evaluate using conventional research methods alone.

The company also believes AI could unlock value from decades of existing oncology research. Numerous antibody programs across the industry have demonstrated promising efficacy but ultimately failed because of safety concerns. By analyzing historical clinical and preclinical datasets, AI may help identify new dual-target combinations that preserve therapeutic activity while avoiding the toxicities that limited earlier approaches, potentially bringing previously failed therapies back from the dead.

“We see enormous potential in the application of AI processes to help guide the development strategy of our proprietary BiTAC programs,” commented Christoph Antz, Ph.D., CEO and Co-Founder of VERAXA. “Because of the nature of BiTACs, smart cancer target selection and thorough validation from the outset can have a transformative impact on future success rates and product profiles. This collaboration represents a strategic step forward in harnessing the power of AI to bring precision oncology therapies to patients faster” (https://ibn.fm/LOrJG).

For more information, visit the company’s website at www.veraxa.com.  

NOTE TO INVESTORS: The latest news and updates relating to VRXA are available in the company’s newsroom at https://ibn.fm/VRXA